نتایج جستجو برای: مارکر her1

تعداد نتایج: 1560  

ژورنال: :مجله دانشگاه علوم پزشکی مازندران 0
قاسم جان بابایی ghasem janbabaee cancer research center, department of internal medicine, faculty of medicine, mazandaran university of medical sciences, sari, iranمرکز تحقیقات سرطان، گروه داخلی، دانشکده پزشکی، دانشگاه علوم پزشکی مازندران فرشاد نقش وار farshad naghshvar cancer research center, department of pathology, faculty of medicine, mazandaran university of medical sciences, sari, iranساری: بلوار امیرمازندرانی، مرکز آموزشی درمانی امام خمینی(ره) مر کز تحقیقات سرطان تورج فرازمندفر tooraj farazmandfar cancer research center, department of internal medicine, faculty of medicine, mazandaran university of medical sciences, sari, iranمرکز تحقیقات سرطان، گروه داخلی، دانشکده پزشکی، دانشگاه علوم پزشکی مازندران مصطفی صالحی mostafa salehi cancer research center, department of pathology, faculty of medicine, mazandaran university of medical sciences, sari, iranمرکز تحقیقات سرطان، گروه پاتولوژی، دانشکده پزشکی، دانشگاه علوم پزشکی مازندران معصومه رشیدی masoomeh rashidi cancer research center, department of pathology, faculty of medicine, mazandaran university of medical sciences, sari, iranمرکز تحقیقات سرطان، گروه پاتولوژی، دانشکده پزشکی، دانشگاه علوم پزشکی مازندران

سابقه و هدف: میزان مرگ ناشی از سرطان معده در جهان رو به افزایش است. امروزه در بسیاری از سرطان ها ارتباط بسیار دقیقی بین ایجاد سرطان و تغییر میزان بیان رسپتور egf وجود دارد. شاید شناخته شده ترین این تغییرات بیان بالای گیرنده های her2 و her1 در سرطان معده باشد. هدف این مطالعه بررسی میزان بیان این دو گیرنده در آدنوکارسینوم های پیشرفته موضعی معده و ارتباط آن با بقاء بیماران می باشد. مواد و روش ها: ...

Abasalt Hosseinzadeh Colagar , Alireza Rafiei, Omolbanin Amjadi , Reza Valadan,

Background: Understanding of cellular and molecular mechanisms involved in cell/tumor growth and progression has led to molecular-targeted therapy. HER1 and HER2 are two main oncogenic components of HER-receptor family considered as targets for cancer research and therapy. Reliable results of HER- related research and targeted therapies dependent upon cell line with known HER expression status....

2008
Belinda Sánchez Yeranddy Aguiar Greta Garrido Ailem Rabasa Diana R Fernández Rolando Pérez Luis E Fernández

Epidermal Growth Factor Receptor (EGFR or HER1) is considered a tumor associated antigen. HER1 is overexpressed in many human epithelial tumors and involved in crucial cellular functions for tumor development. For this reason HER1 is considered a good target for cancer immunotherapy and some passive agents are being evaluated in clinical trials. However, HER1-based active immunotherapy has not ...

2017
Iraida Caballero Lazaro E. Aira Anabel Lavastida Xitlally Popa Javier Rivero Joaquín González Mónica Mesa Narjara González Kelly Coba Patricia Lorenzo-Luaces Barbara Wilkinson Yuliannis Santiesteban Yanela Santiesteban Mayelin Troche Eduardo Suarez Tania Crombet Belinda Sánchez Angel Casacó Amparo Macías Zaima Mazorra

Metastatic castration-resistant prostate cancer (CRPC) remains incurable due to the lack of effective therapies. Activation of the human epidermal growth factor receptor 1 (HER1) in prostate cancer contributes to metastatic progression as well as to disease relapse. Here, we determined the toxicity and immunogenicity of a HER1-based cancer vaccine in CRPC patients included in a phase I clinical...

Journal: :research in molecular medicine 0
abasalt hosseinzadeh colagar omolbanin amjadi reza valadan alireza rafiei

background: understanding of cellular and molecular mechanisms involved in cell/tumor growth and progression has led to molecular-targeted therapy. her1 and her2 are two main oncogenic components of her-receptor family considered as targets for cancer research and therapy. reliable results of her- related research and targeted therapies dependent upon cell line with known her expression status....

2012
Suma Choorapoikayil Bernd Willems Peter Ströhle Martin Gajewski

Somitogenesis is controlled by a genetic network consisting of an oscillator (clock) and a gradient (wavefront). The "hairy and Enhancer of Split"- related (her) genes act downstream of the Delta/Notch (D/N) signaling pathway, and are crucial components of the segmentation clock. Due to genome duplication events, the zebrafish genome, possesses two gene copies of the mouse Hes7 homologue: her1 ...

2012
Janelle Weaver

Rhythms underlie a range of biological phenomena, from circadian clocks to cellular responses to DNA damage. The formation of body parts is no exception. During development, the cyclical expression of genes is crucial for regulating the sequential formation of body segments called somites in vertebrates, including zebrafish. Members of the hes/her family of genes are expressed in a rhythmic fas...

Journal: :Development 2013
Anja Hanisch Maxine V Holder Suma Choorapoikayil Martin Gajewski Ertugrul M Özbudak Julian Lewis

A gene expression oscillator called the segmentation clock controls somite segmentation in the vertebrate embryo. In zebrafish, the oscillatory transcriptional repressor genes her1 and her7 are crucial for genesis of the oscillations, which are thought to arise from negative autoregulation of these genes. The period of oscillation is predicted to depend on delays in the negative-feedback loop, ...

2012
Antonella Rigo Michele Gottardi Ernesto Damiani Massimiliano Bonifacio Isacco Ferrarini Pierluigi Mauri Fabrizio Vinante

In the human neoplastic cell lines 5637 and HeLa, recombinant CXCL12 elicited, as expected, downstream signals via both G-protein-dependent and β-arrestin-dependent pathways responsible for inducing a rapid and a late wave, respectively, of ERK1/2 phosphorylation. In contrast, the structural variant [N33A]CXCL12 triggered no β-arrestin-dependent phosphorylation of ERK1/2, and signaled via G pro...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2006
Tai W Wong Francis Y Lee Chiang Yu Feng R Luo Simone Oppenheimer Hongjian Zhang Richard A Smykla Harold Mastalerz Brian E Fink John T Hunt Ashvinikumar V Gavai Gregory D Vite

PURPOSE The studies described here are intended to characterize the ability of BMS-599626, a small-molecule inhibitor of the human epidermal growth factor receptor (HER) kinase family, to modulate signaling and growth of tumor cells that depend on HER1 and/or HER2. EXPERIMENTAL DESIGN The potency and selectivity of BMS-599626 were assessed in biochemical assays using recombinant protein kinas...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید